News & Updates — FORE Announcements
Urban Institute to Assess Impact of Medicaid on Access to Opioid Use Disorder Medications
June 11, 2025FORE today announced it is awarding a $250,500 grant to the Urban Institute to build and maintain a public-facing data dashboard that will track Medicaid coverage of medications used to treat opioid use disorder (OUD) and reverse opioid overdoses. As Medicaid is the largest payer of OUD treatment in the U.S., changes to the program could impact recent progress in reducing overdose deaths, which fell by approximately 25 percent over the past year.
“As the single largest payer of OUD treatment, Medicaid is a lifeline for many individuals, including low-income youth, pregnant and parenting patients, justice-involved populations, and historically underserved communities,” said Karen A. Scott, MD, MPH, President of FORE. “This dashboard will provide actionable data that helps decision-makers respond effectively to maintain access to lifesaving medications.”
In addition to the dashboard, the Urban Institute will publish a series of issue briefs to inform federal and state Medicaid policymakers, congressional staff, managed care plans, and other stakeholders about the evolving landscape of medication access. This grant is part of FORE’s commitment to advancing policy solutions that expand access to effective OUD treatment nationwide.
This effort builds on FORE’s broader work related to Medicaid. Earlier this year, FORE hosted a national webinar, Medicaid’s Ongoing Critical Role in the U.S. Response to the Opioid and Overdose Crisis, which explored the program’s essential contributions to prevention, treatment access, and recovery services.
Additional tools and insights—including webinar recordings, policy briefs, and research—are available in this Medicaid Resources document, offering stakeholders practical guidance for navigating and shaping Medicaid policy.